Evogene (EVGN) Shares Outstanding (Diluted Average) (2020 - 2025)

Evogene (EVGN) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 38.21% to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, up 38.21% year-over-year, with the annual reading at $7.9 million for FY2025, 38.21% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $7.9 million in Q4 2025 for Evogene, up from $5.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $40.4 million in Q4 2021 to a low of $4.1 million in Q4 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $12.5 million across 5 years, with a median of $5.7 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 43.59% in 2021 and later crashed 89.76% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $40.4 million in 2021, then plummeted by 89.76% to $4.1 million in 2022, then increased by 10.81% to $4.6 million in 2023, then rose by 24.14% to $5.7 million in 2024, then soared by 38.21% to $7.9 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for EVGN at $7.9 million in Q4 2025, $5.7 million in Q4 2024, and $4.6 million in Q4 2023.